Goldman Sachs Intuitive Surgical call goes against the grain
Intuitive Surgical (ISRG) has been one of the year’s most punished large-cap healthcare names. The maker of the da Vinci surgical robot has watched its stock fall about 28% in 2026, even as revenue keeps climbing. Analysts have piled on. Deutsche Bank slashed its target. Bank of America trimmed its own. The mood around the […]
Goldman Sachs Intuitive Surgical call goes against the grain Read More »
